Moreover, adipokine imbalance, such as increased serum leptin levels and decreased serum adiponectin levels, is critically involved in obesity- and diabetes-related liver tumorigenesis [17–20], indicating that improving adipokine imbalance may be effective in preventing liver tumorigenesis. This evidence concerns the gene ADIPOQ and obesity disorder.